連続注入によって投与されるメラノコルチン-4受容体(MC4R)アゴニストペプチドの使用

Japanese Patent JP2007530674

A

The present invention provides a method of inducing weight loss in a patient, comprising continuous infusion of an effective amount of an MC4R agonist peptide into the patient. Additionally, the present invention provides a method of treating obesity in a patient, comprising continuous infusion of an effective amount of an MC4R agonist peptide into the patient. Furthermore, the present invention provides the use of an MC4R agonist peptide for the manufacture of a medicament for the treatment of obesity, wherein the medicament is administered by continuous infusion.

WO/2000/073322	HUMAN CARBAMYL PHOSPHATE SYNTHETASE I POLYMORPHISM AND DIAGNOSTIC AND THERAPEUTIC METHODS RELATING THERETO
WO/2018/217897	COMPOSITIONS AND METHOD FOR INDUCING AN IMMUNE RESPONSE
JPH0733336	[Title of the Invention] A combination anticoagulant of LACI and sulfated polysaccharide

Mark Lewis Hayman
Jean El Herter

JP2007506119A

November 01, 2007

June 17, 2004

Click for automatic bibliography generation  

Eli Lilly and Company

A61K38/00; A61K9/00; A61K9/08; A61K9/10; A61K38/12; A61P3/04; A61P43/00; C07K7/64

Kyousei Tamura
Toshio Ueda
Nagatoshi Shinagawa

Previous Patent: テトラキス（フルオロアリール）ホウ酸塩の製造方法

Next Patent: 抗ＣＳ１抗体の治療的使用